Pyoderma gangrenosum following breast reconstructive surgery: A case report of treatment with immunosuppression and adjunctive xenogeneic matrix scaffolds

Journal of Drugs in Dermatology

Volumn 10, Issue 5, 2011, Pages 545-547

  Reddy, Rupa ^a   Favreau, Tracy ^a   Stokes, Tracey ^b   Skopit, Stanley ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Broward General Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN; LEVOFLOXACIN; METHYLPREDNISOLONE; PREDNISONE; TAMOXIFEN; VANCOMYCIN; IMMUNOSUPPRESSIVE AGENT; TISSUE SCAFFOLD;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST RECONSTRUCTION; BREAST SURGERY; CASE REPORT; DEBRIDEMENT; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANT; LEUKOCYTOSIS; PYODERMA GANGRENOSUM; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP; WOUND DEHISCENCE; WOUND HEALING; XENOGRAFT; BREAST TUMOR; EXTRACELLULAR MATRIX; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATHOLOGY; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAMMAPLASTY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PYODERMA GANGRENOSUM; SURGICAL FLAPS; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 80051628069     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: Classification and management. J Am Acad Dermatol. 1996;34:395-409. (Pubitemid 26083814)
2. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum: A comparison of typical and atypical forms with an emphasis on time to remission; Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37-46. (Pubitemid 30077735)
3. Davis MD, Alexander JL, Prawer SE. Pyoderma gangrenoum of the breasts precipitated by breast surgery. J Am Acad Dermatol. 2006;55:317-320. (Pubitemid 44038020)
4. Ouazzani A, Berthe JV, DeFontaine S. Post-surgical pyoderma gangrenosum: A clinical entity. Acta Chir Belg. 2007;107:424-428.
5. MacKenzie D, Moiemen N, Frame JD. Pyoderma gangrenosum following breast reconstruction. Br Jof Plast Surg. 2004;57:69-81.
6. Horner B, El-Muttardi N, Mercer D. Pyoderma gangrenoum complicating bilateral breast reduction. Br Ass of Plast Surg 2004;57:679-81. (Pubitemid 40348051)
7. Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: A review and update on new therapies. J Am Acad Dermatol. 2010;62:646-654.
8. Schintler MV, Grohman M, Donia C, Aberer E, Scharnagl E. Management of an unfortunate triad after breast reconstruction: Pyoderma gangrenosum, full-thickness chest wall defect and acinetobacter baumannii infection. J Plast Reconstr Aesthet Surg. 2010;63(7):564-567. Epub February 11, 2010.
9. Kaddoura IL, Amm C. A rationale for adjuvant surgical intervention in pyoderma gangrenosum. Ann Plast Surg. 2001;46(1):23-28. (Pubitemid 32050393)
10. Alam M, Grossman ME, Schneriderman PI, Blume RS, Benvenisty AI. Surgical management of pyoderma gangrenosum: Case report and review. Dermatol Surg. 2000;26(11):1063-1066.
11. Davis JC, Landeen JM, Levine RA. Pyoderma gangrenosum: Skin grafting after preparation with hyperbaric oxygen. Plast Reconstr Surg. 1987;79:200.
12. Limova M, Mauro T. Treatment of pyoderma gangrenosum with cultured keratinocyte autografts. J Dermatol Surg Oncol. 1994;20(12):833-836.
13. Hu S, Kirsner RS, Falanga V, Phillips T, Eaglstein WH. Evaluation of Apligraf® persistence and basement membrane restoration in donor site wounds: A pilot study. Wound Rep Reg. 2006;14:427-433. (Pubitemid 44266599)
14. Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accerlerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol. 2001;44:61-66. (Pubitemid 32110563)
15. Long RE, Falabella AF, Valencia I, Eaglstein WH, Kirsner RS. Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (Apligraf). Arch Dermatol. 2001;137:1660-1661. (Pubitemid 34000927)
16. Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transplant Immunology. 2004;12:367-377. (Pubitemid 38639730)
17. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Cell & Developmental Biology. 2002;13:377-383. (Pubitemid 35300815)
18. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 2006;12:519-526. (Pubitemid 43673457)